Department of Interventional Cardiology at McGill University Health Centre (MUHC), Montreal, Canada;
Ann Cardiothorac Surg. 2012 Jul;1(2):206-15. doi: 10.3978/j.issn.2225-319X.2012.06.08.
Transcatheter aortic valve implantation (TAVI) has emerged as a highly effective minimally invasive treatment symptomatic for severe calcific aortic stenosis in patients at high or prohibitive surgical risk. The success of TAVI has been determined by a number of factors, but in particular by appropriate patient selection. Appropriate patient selection involves identifying patients with the potential to benefit most from TAVI and individualizing the bioprosthesis type and size, and the vascular access site for each case. We present herein, our critical appraisal on patient selection for TAVI: an interventional cardiology perspective.
经导管主动脉瓣置换术(TAVI)已成为一种非常有效的微创治疗方法,适用于高危或禁忌手术的重度钙化性主动脉瓣狭窄患者。TAVI 的成功取决于多个因素,但特别是适当的患者选择。适当的患者选择涉及确定最有可能从 TAVI 中获益的患者,并为每个病例个体化生物假体类型和大小以及血管入路部位。我们在此介绍了我们对 TAVI 患者选择的批判性评估:介入心脏病学的观点。